GlycoMimetics Inc (NASDAQ:GLYC)
| 7.24 Data as of 3:59pm ET |  +0.09 / +1.26%Today’s Change | 6.02 Today|||52-Week Range 18.99 | +0.56% Year-to-Date |
Latest GLYC News | Press Releases
No recent news for GlycoMimetics Inc.
Today’s Trading
| Previous close | 7.15 |
| Today’s open | 7.24 |
| Day’s range | 7.03 - 7.24 |
| Volume | 24,051 |
| Average volume (3 months) | 28,141 |
| Market cap | $135.1M |
| Dividend yield | -- |
Data as of 3:59pm ET, 01/29/2015
Growth & Valuation
| Earnings growth (last year) | -272.73% |
| Earnings growth (this year) | +95.08% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -73.83% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 46.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADHDAlcobra Ltd | +0.18 | +2.90% |
| ZSANZosano Pharma Corp | +0.15 | +1.36% |
| RNNRexahn Pharmaceutica... | +0.00 | +0.41% |
| SNSSSunesis Pharmaceutic... | +0.04 | +1.74% |
Data as of 4:00pm ET, 01/29/2015
Financials
| Next reporting date | February 25, 2015 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$10.6M |
| Net profit margin | -265.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
Chief Financial Officer & Head-Media Relations Brian M. Hahn |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
.